Accueil › Leucémie lymphocytaire chronique › District de Columbia › Washington
Essais cliniques pour Leucémie lymphocytaire chronique à Washington, DC
22 études pour Leucémie lymphocytaire chronique recherchent des participants dans et autour de Washington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Recrutement en coursPhase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · à 7 mi
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Recrutement en coursPhase 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · à 7 mi
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Recrutement en coursPhase 3
- GC2202 Study Site 111, Bethesda · à 7 mi
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Recrutement en coursPhase 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Recrutement en coursPhase 3
- American Oncology Partners of Maryland Pa, Bethesda · à 7 mi
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recrutement en coursPhase 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Recrutement en coursPhase 2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Recrutement en coursPhase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · à 7 mi
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Recrutement en coursPhase 2
- Maryland Oncology Hematology, Silver Spring · à 7 mi
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Recrutement en coursPhase 1 précoce
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Recrutement en coursPhase 3
- American Oncology Partners of Maryland, PA, Bethesda · à 7 mi
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Recrutement en coursPhase 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · à 7 mi
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
Recrutement en coursPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recrutement en coursPhase 1
- National Institute of Health, Bethesda · à 7 mi
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Recrutement en coursPhase 2
- American Oncology Partners, PA, Bethesda · à 7 mi
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Recrutement en coursPhase 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · à 7 mi
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · à 7 mi
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Recrutement en coursPhase 1
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Essais pour Leucémie lymphocytaire chronique dans d'autres villes
- Boston, MA31 études
- Columbus, OH28 études
- Durham, NC27 études
- Seattle, WA20 études
- New York City, NY18 études
- Rochester, MN18 études
- Houston, TX17 études
- Baldwin Park, CA16 études
- Milwaukee, WI15 études
- Chicago, IL14 études
- Cincinnati, OH14 études
- Nashville, TN13 études
Autres études à Washington
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules55 études
- Cancer du sein46 études
- Cancer métastatique43 études
- Cancer du poumon41 études
- Cancer de la prostate38 études
- Obésité33 études
- Cancer colorectal29 études
- Maladie cardiovasculaire28 études
- Cancer de la vessie26 études
- Leucémie aiguë myéloïde24 études
- Cancer de l'ovaire23 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.